EGFR and hepatocellular carcinoma: Yang employed a quantitative proteomics strategy to globally identify CDR1as-regulated proteins in hepatocellular carcinoma (HCC) cells and identified 330 differentially expressed proteins upon enhanced CDR1as expression in HepG2 cells, specifically, CDR1as may exert its function by regulating EGFR expression by targeting miR-7 in HCC cells [60].